BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/26/2019 12:19:02 AM | Browse: 1092 | Download: 1895
 |
Received |
|
2019-07-05 00:43 |
|
Peer-Review Started |
|
2019-07-17 08:51 |
|
First Decision by Editorial Office Director |
|
2019-10-14 22:39 |
|
Return for Revision |
|
2019-10-15 00:50 |
|
Revised |
|
2019-11-13 09:10 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2019-11-15 08:08 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2019-11-19 04:19 |
|
Articles in Press |
|
2019-11-19 04:19 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-12-18 07:19 |
|
Publish the Manuscript Online |
|
2019-12-26 00:19 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Editorial |
| Article Title |
Are all prostate cancer patients "fit" for salvage radiotherapy?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Carmen González-San Segundo, Alfonso Gómez-Iturriaga and Felipe Couñago |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Carmen González-San Segundo, MD, PhD, Professor, Research Scientist, Staff Physician, Department of Radiation Oncology, HGU Gregorio Marañon, Complutense University, C/Doctor Esquerdo 46, Madrid 28007, Spain. cglezss@gmail.com |
| Key Words |
Prostate cancer; Salvage radiotherapy; Comorbidity; Fit; Androgen deprivation therapy; |
| Core Tip |
Salvage radiotherapy (SRT) is an effective treatment for biochemically-recurrent prostate cancer after prostatectomy. Proper patient selection is crucial. While tumour-related factors are important, the indication for SRT should also be based on clinical factors and dosimetric variables. Patients with non-aggressive tumours who have a life expectancy of less than 10 years are unlikely to benefit from radiotherapy and should thus be considered "unfit" for SRT. The development of advanced imaging techniques such Ga-PSMA positron emission tomography/computed tomography, which are capable of localizing the recurrent lesion when prostate-specific antigen ≤ 0.5 ng/mL, has forced clinicians to reconsider whether patients should undergo radiotherapy without locate first the recurrence. |
| Publish Date |
2019-12-26 00:19 |
| Citation |
González-San Segundo C, Gómez-Iturriaga A, Couñago F. Are all prostate cancer patients "fit" for salvage radiotherapy? World J Clin Oncol 2020; 11(1): 1-10 |
| URL |
https://www.wjgnet.com/2218-4333/full/v11/i1/1.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v11.i1.1 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
